Documented safety problems with compounded semaglutide consist of dosing problems from incorrect compounding or mislabeling, contamination with microbes or other dangerous substances all through preparation, presence of impurities or unintended components, utilization of non-pharmaceutical grade Energetic substances from unregistered suppliers, and